Skip to main content
. 2008 Dec 16;100(1):89–95. doi: 10.1038/sj.bjc.6604814

Table 4. Prognostic significance of EGFR status in type II endometrial cancer patients using multivariate analysis.

Parameter Risk ratio (95% CI) Wald test
Age 1.06 (1.03, 1.09) P=0.0002
     
Stage
 1–2 (reference) 1.0  
 3 3.23 (1.24, 8.40) P=0.0160
 4 11.8 (5.33, 26.2) P<0.0001
     
EGFR
 Negative (reference) 1.0  
 Positive 1.81 (1.10, 2.99) P=0.0197

A stepwise method was used for variable selection. EGFR expression, stage, and age were selected as significant prognostic factors.